Drug shortage
Atropa Belladonna · Padagis US LLC
FDA drug shortage · Resolved · updated Jan 14, 2025
Key facts
| Generic name | Atropa Belladonna, Opium Suppository |
|---|---|
| Proprietary name | Belladonna And Opium |
| Company | Padagis US LLC |
| Presentation | Belladonna And Opium, Suppository, 16.2 mg; 60 mg (NDC 0574-7040-12) |
| Dosage form | Suppository |
| Strength | 16.2 mg 60 mg |
| Status | Resolved |
| Therapeutic category | Urology |
| Package NDCs | 0574-7040-12 |
| First posted | Aug 3, 2022 |
| Last updated | Jan 14, 2025 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: